Evidence map›Paper›PMID 41157055›Full record

ReviewMolecules (Basel, Switzerland)2025

USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.

Matteo Lusardi, Federica Rapetti, Andrea Spallarossa, Marta Massone, Elena Cichero, Chiara Brullo

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. USP7 at PML Nuclear Bodies: A Protein Interaction Network Perspective.International journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matteo LusardiDepartment of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.ORCID 0000-0002-7003-7891
Federica RapettiDepartment of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.ORCID 0000-0002-4032-323X
Andrea SpallarossaDepartment of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.ORCID 0000-0002-3360-7146
Marta MassoneDepartment of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.
Elena CicheroDepartment of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.
Chiara BrulloDepartment of Pharmacy, University of Genoa, Viale Benedetto XV 3, 16132 Genova, Italy.ORCID 0000-0002-2575-7726

Funding

European Union PNRR M4.C2 - Investimento 1.2 "Finanziamento di progetti presentati da giovani ricercatori" D.D. n. 47/2025, Project CUP D33C25000300001
6 · The paper itself

Abstract

Protein homeostasis is a dynamic process essential for cellular function and survival, tightly controlled by the ubiquitin-proteasome system. Within this system, ubiquitin-specific protease 7 (USP7) plays a key role as a deubiquitinating enzyme, thus modulating the stability, localization, and activity of a wide variety of substrates. USP7 is involved in critical cellular processes such as DNA repair, apoptosis, immune response, and epigenetic regulation. The dysregulation of USP7 expressions or activity has been linked to several pathological conditions, including cancer, neurodegenerative and inflammatory diseases, and viral infections. This enzyme exerts its biological functions through the stabilization of both oncogenic and tumor suppressor proteins, highlighting its sensitive role in tumorigenesis. Despite the identification of selective USP7 inhibitors with promising preclinical activity, the development of clinically effective compounds remains a major challenge. This review summarizes the current understanding of USP7 structure, function, and biological relevance, with a particular emphasis on its potential as a therapeutic target in oncology.

Indexed as

CarcinogenesisCell CycleSignal TransductionUbiquitinUbiquitin-Specific Peptidase 7AnimalsHumansNeoplasmsUbiquitinUbiquitin-Specific Peptidase 7USP7 protein, humandeubiquitinationtumorigenesisUbiquitin-proteasome systemUSP7USP7 activatorsUSP7 inhibitors

Identifiers

PMID41157055
PMCPMC12566277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.